# Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis

> **NCT04886258** · PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 115 (actual)

## Conditions studied

- Symptomatic Knee Osteoarthritis

## Interventions

- **DRUG:** DFV890
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04886258
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-20
- **Primary completion:** 2024-12-14
- **Final completion:** 2024-12-23
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04886258

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04886258, "Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04886258. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*